Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch
Centre Hospitalier Universitaire, Amiens
302 participants
Jun 1, 2025
INTERVENTIONAL
Conditions
Summary
Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.
Eligibility
Inclusion Criteria7
- Adults (\>18 years old).
- Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours.
- Scheduled pneumonectomy or lobectomy.
- Admission to a conventional surgical unit postoperatively.
- Ability to perform single-lead ECG using a smartwatch.
- Coverage under a social security system.
- Signed informed consent
Exclusion Criteria8
- History of atrial fibrillation.
- Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm).
- Dependency on a pacemaker.
- Participation in another interventional clinical trial affecting POAF incidence.
- Mediastinal, pleural, or chest wall surgery.
- Reoperations or surgeries performed more than 48 hours prior.
- Pregnant women.
- Patients under guardians or similar legal protection.
Interventions
Patients in the smartwatch group will undergo rhythm monitoring with a smartwatch
Detected POAF episodes will be confirmed via a 12-lead ECG
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06724718